Biosimilars / / by Valderilio Feijó Azevedo, Robert Moots, editors.
Introduced in the 1980s, biologic medications have since become important tools in modern medicine. However, biologics are expensive, greatly affecting the healthcare budgets of both underdeveloped and developed countries. Fortunately, biosimilars, which are highly similar, reverse-engineered versio...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | London : : IntechOpen,, [2022] |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 online resource (106 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biosimilars / / edited by Valderilio Feijó Azevedo and Robert Moots.
Published: (2022.) -
Biosimilars and biologics : : implementation and monitoring in a healthcare setting / / Steven Lucio.
by: Lucio, Steven,
Published: ([2018]) -
The Politics of Digital Pharmacology : : Exploring the Craft of Collective Care / / Florian Weber-Stein, Felix Heidenreich.
by: Heidenreich, Felix,
Published: ([2022]) -
Drug repurposing : : molecular aspects and therapeutic applications / / edited by Shailendra K. Saxena.
Published: ([2022]) -
Drug Development Life Cycle / / edited by Juber Akhtar [and three others].
Published: (2022.)